Developing a robust formulation is crucial for a successful product launch. We develop all dosage forms and specialize in controlled release formulations. By applying Quality
by Design (QbD) principles and leveraging statistical tools like Design of Experiments, we ensure the development of optimal formulations.
A simple, well-defined process is essential for ensuring product quality, compliance with cGMP regulations, and reducing process costs. We tailor the process to your machinery and equipment, applying Lean Sigma principles to develop a robust and efficient workflow.
Our brand-new tablet production facility, with a capacity of 2.5 billion units per year, is nearing completion. It features high-speed tablet presses, including the Manesty 75-station and Manesty 61-station, enabling the manufacture of large commercial batches.
Suboptimal formulations and inefficient processes can result in costly recalls. Princeton Innovations specializes in reformulating products and enhancing existing processes to meet the highest standards of quality and efficiency.
Princeton Innovations develops, validates, and transfers analytical methods for all formulations. We use statistical tools, including Design of Experiments (DoE), to create robust and reliable methods.
Princeton Innovations tests raw materials, intermediates, finished products, and stability samples, adhering strictly to GLP guidelines to ensure product quality and consumer safety.
Copyright © 2023 Pigenerics - All Rights Reserved.
This website uses cookies. By continuing to use this site, you accept our use of cookies.